Table 4.

Prognostic factors of progression free survival.

95% CIOdds ratioP
Dose0.01351–1.0980.12180.046
Treatment1.289–52.188.2000.039
Extension0.01419–1.0530.12220.036
Visual field defect1.158–23.395.2050.033
Age0.1528–3.3920.72001.00
Gender0.2686–5.9741.2671.00